Miltefosine for Mucosal Leishmaniasis

Phase 1

Completed

• Conditions: Leishmaniasis

• Registration Number: NCT00373776
• Lead Sponsor: AB Foundation

Brief Summary

This trial will study miltefosine as a treatment for mucosal leishmaniasis.

Detailed Description

Treat bolivian mucosal leishmaniasis with miltefosine.

Study Timeline

• Study Start: 2004-04
• Study Completion: 2006-05
• Status Verified: 2006-09
• Study First Submitted: 2006-09-07
• Study First Submitted QC: 2006-09-07
• Last Update Submitted: 2006-09-07
• Study First Posted: 2006-09-08
• Last Update Posted: 2006-09-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• Mucosal leishmaniasis

Exclusion Criteria

• Abnormal liver function tests (LFT)
• Abnormal kidney function test
• Concomitant diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Efficacy

Secondary Outcome Measures

Name	Time	Method
toxicity